FEATURE
SO CLOSE, YET SO FAR, Moderna Efficacy Rate: 94.1% Developed by: ModernaTX, Inc. Shots Required: 2 doses, 28 days apart Like Pfizer, this brand uses mRNA technology, though the slight difference in number, doesn’t mean that this is less effective.
AWAITING, Novavax
Efficacy Rate: N/A Developed by: N/A Shots Required: 2 doses, 21 days apart
This uses the protein subunit technology which is also used in
Hepatitis B, meningococcal disease, pneumococcal disease, shingles. Currently, it is still awaiting for Phase III Clinical Trial.
60 EC Magazines | Summer Edition 2021
Made with FlippingBook Proposal Creator